— Know what they know.
Not Investment Advice

NGEN Short Interest

NervGen Pharma Corp. Common stock
1W: -3.9% 1M: -21.3% 3M: -6.9% YTD: -74.8%
$1.48
+0.06 (+4.23%)
 
Weekly Expected Move ±6.4%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · $159.1M mcap · 90M float · 0.663% daily turnover · Short 46% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z'' -5.72.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
32.1%
Short Ratio
of total volume
57.6%
20-Day Avg
59.3%
50-Day Avg
▼ Falling
5-Day Trend
0.0M
Short Volume
0.1M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 33,445 105,447 31.7%
NYSE 640 662 96.7%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms